Abstract
Chronic obstructive pulmonary disease (COPD) often co-exists with other diseases (comorbidities), of which pneumoconiosis is an important one. The interaction between pneumoconiosis and COPD is manifested in the risk of disease, severity of disease, risk of acute exacerbation and the disease progression, and pharmaceutical and non-pharmaceutical treatment options. At present, there is a general lack of understanding of COPD complications in clinical practice, and there is a lack of clear clinical guidance for diagnosis and management of COPD patients with pneumoconiosis. Based on clinical evidence and experience, and the writing group puts forward five recommendations to improve the recognition and management of COPD patients with pneumoconiosis for medical professionals in hospitals at different levels, particularly in primary medical institutions.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call